- This event has passed.
Risk-based investments in regulatory systems: A global call to action
October 14 @ 8:30 am - 10:30 am
USP, Bill & Melinda Gates Foundation, IFPMA, & London School of Hygiene and Tropical Medicines
8:30 AM – 10:30 AM GTB
One third of the world’s population lacks sustainable and timely access to quality-assured medicine. This global problem undermines the treatment of diseases such as tuberculosis, malaria, and HIV/AIDS, and contributes to antimicrobial resistance (AMR), with the greatest risk in low- and middle-income countries. In collaboration with NRAs, donors, multilateral organizations, non-governmental entities, academia, and the private sector, the United States Pharmacopeia (USP) recently published a peer-reviewed journal article, identifying investment priorities for sustainably strengthening medical product regulatory systems over the next decade.
Join in for a cross-sector panel discussion convened by USP to discuss the challenges and opportunities to strengthen systems and ensure access to quality medicines. Breakfast and registration will begin at 8:30 a.m.